Follow the people · Insider
Mark Wilterding
Mark Wilterding files insider transactions with the SEC as a chief financial officer of RxSight (RXST). We hold 1 disclosed purchase or sale filed since 30 January 2026, 1 of them in the last 90 days.
- Files forRXST
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure2 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 12 January 2026 — 2 September 2026Chief Financial Officer · RxSight (RXST)13 Form 4 lines · source: SEC Form 4
Everything they disclosed
13 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 20,441 shares of RxSightSEC Form 42 September 2026Common Stock · traded 31 August 2026 · filed 2 September 2026
- ▼ sold on the open market 7,765 shares of RxSightSEC Form 42 September 2026Common Stock · traded 2 September 2026 · filed 2 September 2026
- exercised options over 20,441 shares of RxSight (a derivative holding)SEC Form 42 September 2026Restricted Stock Unit · traded 31 August 2026 · filed 2 September 2026
- exercised options over 20,441 shares of RxSightSEC Form 43 March 2026Common Stock · traded 28 February 2026 · filed 3 March 2026
- had shares withheld for tax on 8,068 shares of RxSightSEC Form 43 March 2026Common Stock · traded 28 February 2026 · filed 3 March 2026
- exercised options over 20,441 shares of RxSight (a derivative holding)SEC Form 43 March 2026Restricted Stock Unit · traded 28 February 2026 · filed 3 March 2026
- exercised options over 20,441 shares of RxSight (a derivative holding)SEC Form 43 March 2026Restricted Stock Unit · traded 28 February 2026 · filed 3 March 2026
- exercised options over 20,441 shares of RxSightSEC Form 43 March 2026Common Stock · traded 28 February 2026 · filed 3 March 2026
- had shares withheld for tax on 8,068 shares of RxSightSEC Form 43 March 2026Common Stock · traded 28 February 2026 · filed 3 March 2026
- was granted 258,770 shares of RxSight (a derivative holding)SEC Form 430 January 2026Stock Option (right to buy) · traded 12 January 2026 · filed 30 January 2026
- was granted 163,528 shares of RxSight (a derivative holding)SEC Form 430 January 2026Restricted Stock Unit · traded 12 January 2026 · filed 30 January 2026
- was granted 258,770 shares of RxSight (a derivative holding)SEC Form 430 January 2026Stock Option (right to buy) · traded 12 January 2026 · filed 30 January 2026
- was granted 163,528 shares of RxSight (a derivative holding)SEC Form 430 January 2026Restricted Stock Unit · traded 12 January 2026 · filed 30 January 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.